Home Cart 0 Sign in  
X

[ CAS No. 461-82-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 461-82-5
Chemical Structure| 461-82-5
Chemical Structure| 461-82-5
Structure of 461-82-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 461-82-5 ]

Related Doc. of [ 461-82-5 ]

Alternatived Products of [ 461-82-5 ]

Product Details of [ 461-82-5 ]

CAS No. :461-82-5 MDL No. :MFCD00041314
Formula : C7H6F3NO Boiling Point : -
Linear Structure Formula :- InChI Key :XUJFOSLZQITUOI-UHFFFAOYSA-N
M.W : 177.12 Pubchem ID :600848
Synonyms :

Calculated chemistry of [ 461-82-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 37.53
TPSA : 35.25 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.85 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.63
Log Po/w (XLOGP3) : 2.16
Log Po/w (WLOGP) : 3.44
Log Po/w (MLOGP) : 1.64
Log Po/w (SILICOS-IT) : 1.67
Consensus Log Po/w : 2.11

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.54
Solubility : 0.514 mg/ml ; 0.0029 mol/l
Class : Soluble
Log S (Ali) : -2.53
Solubility : 0.519 mg/ml ; 0.00293 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.66
Solubility : 0.385 mg/ml ; 0.00217 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.21

Safety of [ 461-82-5 ]

Signal Word:Danger Class:8,6.1
Precautionary Statements:P210-P261-P280-P301+P310-P305+P351+P338 UN#:2922
Hazard Statements:H227-H301+H311+H331-H315-H318-H373 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 461-82-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 461-82-5 ]
  • Downstream synthetic route of [ 461-82-5 ]

[ 461-82-5 ] Synthesis Path-Upstream   1~35

  • 1
  • [ 461-82-5 ]
  • [ 828-27-3 ]
YieldReaction ConditionsOperation in experiment
50g With sulfuric acid; sodium nitrite In water at 5 - 110℃; for 2 h; The 4-(trifloromethoxy) aniline (75 g) was diazotized in 9N H2S04 (750 mL) and aqueous NaNO2 (31 g in 62 mL water) solution at temperature below 5°C.The formed diazonium saltwas decomposed in boiling 9N H2S04 solution (750 mL)at 110°C for 2hrs. The reaction mixture was cooled to 25°C. The bottom layer ofreaction mixture was separated. The remaining reaction mixture was extracted with dichloromethane. All organic layers were combined, dried over Na2SO4, filtered and evaporated to obtain the title compound.Yield: 50 gPurity: 99.5percent
Reference: [1] Journal of Medicinal Chemistry, 1982, vol. 25, # 9, p. 1097 - 1101
[2] Patent: WO2016/125185, 2016, A2, . Location in patent: Page/Page column 9
  • 2
  • [ 461-82-5 ]
  • [ 828-27-3 ]
  • [ 108-95-2 ]
Reference: [1] Patent: US5171857, 1992, A,
[2] Patent: US4925839, 1990, A,
[3] Patent: US4983612, 1991, A,
  • 3
  • [ 461-82-5 ]
  • [ 9005-25-8 ]
  • [ 828-27-3 ]
  • [ 108-95-2 ]
Reference: [1] Patent: EP566567, 1997, B1,
  • 4
  • [ 461-82-5 ]
  • [ 2252-44-0 ]
YieldReaction ConditionsOperation in experiment
37 %Chromat.
Stage #2: With bromine In acetic acid at 0 - 5℃;
EXAMPLE 5 (COMPARATIVE) Preparation of l-bromo-3-trifluoromethoxybenzene with Br2 in acetic acid. 60 g of acetic acid are placed in a 100 cc flask, then slowly 30 g of 4- trifluoromethoxyaniline are added; the mixture is brought to 0-5°C and 27 g of elementary bromine are metered, slowly. A gas chromatograph analysis is performed at the end of the reaction:20percent of 4-trifluoromethoxyaniline, 37percent of mono-bromo-derivative as per the title, >41 percent of di-bromo-derivative.
34 %Chromat. With bromine In water at 35℃; for 2 h; EXAMPLE 6 (COMPARATIVE) Preparation of l-bromo-3-trifluoromethoxybenzene with Br2 in water. 17.7 g of 4-trifluoromethoxyaniline and 53 g of water at room temperature are placed in a 100 cc flask, the mixture is brought to 35°C and 32 g of elementary bromine are metered slowly over a period of 2 hours. After 0.8 equivalents, a gas chromatograph analysis is performed:10percent of 4-trifluoromethoxyaniline, 34percent of mono-bromo-derivative as per the title, 54percent of di-bromo-derivative.
Reference: [1] Patent: WO2007/107820, 2007, A2, . Location in patent: Page/Page column 9
[2] Patent: WO2007/107820, 2007, A2, . Location in patent: Page/Page column 9
  • 5
  • [ 713-65-5 ]
  • [ 461-82-5 ]
Reference: [1] Russian Journal of Organic Chemistry, 2002, vol. 38, # 2, p. 269 - 271
[2] Patent: WO2016/125185, 2016, A2, . Location in patent: Page/Page column 8
[3] Patent: CN106083601, 2016, A, . Location in patent: Paragraph 0027-0030
[4] Patent: CN108383737, 2018, A, . Location in patent: Paragraph 0011; 0020-0026
  • 6
  • [ 407-14-7 ]
  • [ 461-82-5 ]
YieldReaction ConditionsOperation in experiment
62%
Stage #1: With magnesium; ethylene dibromide In tetrahydrofuranInert atmosphere
Stage #2: With C10H17NO In tetrahydrofuran; toluene at -20℃; for 2 h; Inert atmosphere
General procedure: To a flame-dried 25 mL round bottom flask was charged activated Mg (7.5 mmol, 1.5 eq.) and 5 mL anhydrous THF. To this suspension was added 2 drops of 1,2-dibromoethane. After 5 min, a solution of Aryl bromide (5 mmol, 1.0 eq.) in 5 mL anhydrous THF was slowly added to the suspension of Mg at room temperature. The reaction was mildly exothermic. The Grignard reagent was titrated and 1 mmol of this reagent was added to a flame-dried reaction vial. The solution was diluted with 3 mL anhydrous toluene and after cooling to the target temperature T, a solution of oxaziridine (1.2 mmol, 1.2 eq.) in 1 mL anhydrous toluene was added. The reaction was maintained at the targeted temperature T for time t before being quenched with saturated aqueous NH4Cl. (The actual temperature/reaction time is listed for each substrate.)
Reference: [1] Organic Letters, 2013, vol. 15, # 14, p. 3734 - 3737
[2] Nature Chemistry, 2017, vol. 9, # 7, p. 681 - 688
[3] Patent: US2018/57444, 2018, A1, . Location in patent: Paragraph 0098; 0134; 0135; 0171
  • 7
  • [ 82050-00-8 ]
  • [ 461-82-5 ]
Reference: [1] Tetrahedron Letters, 2013, vol. 54, # 9, p. 1169 - 1173
  • 8
  • [ 876012-82-7 ]
  • [ 461-82-5 ]
Reference: [1] Chemistry - An Asian Journal, 2018, vol. 13, # 3, p. 255 - 260
  • 9
  • [ 100-66-3 ]
  • [ 461-82-5 ]
Reference: [1] Patent: WO2016/125185, 2016, A2,
  • 10
  • [ 34888-05-6 ]
  • [ 461-82-5 ]
Reference: [1] Patent: WO2016/125185, 2016, A2,
  • 11
  • [ 456-55-3 ]
  • [ 461-82-5 ]
Reference: [1] Patent: WO2016/125185, 2016, A2,
  • 12
  • [ 456-71-3 ]
  • [ 461-82-5 ]
Reference: [1] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 518,522; engl. Ausg. S. 587, 591
  • 13
  • [ 36823-89-9 ]
  • [ 461-82-5 ]
Reference: [1] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 518,522; engl. Ausg. S. 587, 591
  • 14
  • [ 332-25-2 ]
  • [ 461-82-5 ]
Reference: [1] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 518,522; engl. Ausg. S. 587, 591
  • 15
  • [ 100114-88-3 ]
  • [ 461-82-5 ]
Reference: [1] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 518,522; engl. Ausg. S. 587, 591
  • 16
  • [ 330-11-0 ]
  • [ 461-82-5 ]
Reference: [1] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 518,522; engl. Ausg. S. 587, 591
  • 17
  • [ 100-07-2 ]
  • [ 461-82-5 ]
Reference: [1] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 518,522; engl. Ausg. S. 587, 591
  • 18
  • [ 874-90-8 ]
  • [ 461-82-5 ]
Reference: [1] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 518,522; engl. Ausg. S. 587, 591
  • 19
  • [ 461-82-5 ]
  • [ 658-89-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 24, p. 8541 - 8554
  • 20
  • [ 461-82-5 ]
  • [ 2267-23-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 10, p. 1786 - 1792
[2] Patent: WO2006/22954, 2006, A2, . Location in patent: Page/Page column 23
  • 21
  • [ 461-82-5 ]
  • [ 109-77-3 ]
  • [ 370-86-5 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 11, p. 1341 - 1343
[2] Tetrahedron, 2010, vol. 66, # 13, p. 2384 - 2389
  • 22
  • [ 461-82-5 ]
  • [ 133840-96-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 15, p. 2828 - 2843
  • 23
  • [ 461-82-5 ]
  • [ 103962-05-6 ]
Reference: [1] Chemistry - A European Journal, 2018, vol. 24, # 55, p. 14622 - 14626
[2] Chinese Chemical Letters, 2015, vol. 26, # 10, p. 1307 - 1310
[3] Organic Letters, 2018, vol. 20, # 17, p. 5167 - 5171
  • 24
  • [ 288-88-0 ]
  • [ 461-82-5 ]
  • [ 103962-05-6 ]
Reference: [1] Patent: US4925863, 1990, A,
  • 25
  • [ 103962-04-5 ]
  • [ 461-82-5 ]
  • [ 103962-05-6 ]
Reference: [1] Patent: EP174769, 1991, B1,
  • 26
  • [ 461-82-5 ]
  • [ 175203-85-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1998, vol. 6, # 4, p. 389 - 399
  • 27
  • [ 461-82-5 ]
  • [ 196811-90-2 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 30, p. 12466 - 12469
[2] Journal of the American Chemical Society, 2012, vol. 134, # 43, p. 18147 - 18147,1
  • 28
  • [ 461-82-5 ]
  • [ 175278-17-8 ]
YieldReaction ConditionsOperation in experiment
83% With N-bromosuccinamide In acetonitrile at 0 - 20℃; for 4 h; N-Bromosuccinamide (3.62 g, 20.34 mmol) was added to a solution of commercially available 4-(trifluoromethoxy)aniline (3.00 g, 1 6.95 mmol) in acetonitrile (30 mL) at 0°C. The resulting mixture was allowed to warm to roomtemperature and stirred for 4 hours. The solvent was removed under reduced pressure to give the crude product which was purified by column chromatography eluting in 10percent ethyl acetat/hexane to afford the title compound as brown oil (3.6 gm, 83percent): 1 H NMR (400 MHz, CDCI3) ö: 4.11 (bs, 2 H), 6.73 (d, 1 H), 6.99 (dd, 1 H), 7.31 (d, 1 H). LC-Ms (m/z): [M-H] = 253.1.
40%
Stage #1: With bromine In acetic acid at 20℃; for 2.16667 h;
Stage #2: With sodium hydroxide In water; acetic acid
4-Trifluoromethoxyaniline (1.0 g, 5.6 mmol) was dissolved in glacial acetic acid (10 mL). Bromine (585 μL, 11 mmol) dissolved in glacial acetic acid (2 mL) was added with stirring during 10 minutes at room temperature. The resulting mixture was stirred at room temperature for 2 hours and then poured into water (100 mL). The solid formed (2,5-dibromo-4-trifluoromethoxyaniline) was filtered off. The filtrate was made alkaline with solid sodium hydroxide and extracted with dichloromethane (100 mL), dried (MgSO4) and concentrated (30°C; 200 mBar) to afford 0.57 g (40percent) of 2-bromo-4-trifluoromethoxyaniline.1H NMR (DMSO-d6): δ 5.55 (2H, bs), 6.85 (1H, d), 7.10 (1H, dd), 7.37 (1H, d).
Reference: [1] Patent: WO2015/100232, 2015, A2, . Location in patent: Page/Page column 102
[2] Journal of Medicinal Chemistry, 2007, vol. 50, # 1, p. 113 - 128
[3] Patent: EP1183229, 2005, B1, . Location in patent: Page/Page column 143-144
[4] Organic Letters, 2011, vol. 13, # 20, p. 5636 - 5639
[5] Journal of the American Chemical Society, 2016, vol. 138, # 40, p. 13147 - 13150
[6] Chinese Journal of Chemistry, 2018, vol. 36, # 9, p. 815 - 818
  • 29
  • [ 302-17-0 ]
  • [ 461-82-5 ]
  • [ 169037-23-4 ]
Reference: [1] Pharmaceutical Chemistry Journal, 2017, vol. 51, # 5, p. 366 - 374
[2] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 20, p. 5630 - 5633
[3] European Journal of Medicinal Chemistry, 2016, vol. 124, p. 809 - 819
  • 30
  • [ 461-82-5 ]
  • [ 169037-23-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 17, p. 2427 - 2430
[2] Patent: WO2012/178015, 2012, A2,
  • 31
  • [ 461-82-5 ]
  • [ 728033-96-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2015, vol. 13, # 14, p. 4296 - 4309
  • 32
  • [ 461-82-5 ]
  • [ 88149-49-9 ]
YieldReaction ConditionsOperation in experiment
99.2% at 30 - 55℃; for 3 h; A method for preparing 2,6-dibromo-4- (trifluoromethoxy) aniline,Including the following steps:The sodium sulfate was filtered off embodiment Example 4 156g crystallization mother liquor into 250mL 4-neck flask,Start stirring dropping 17.5 (0.175mol) sulfuric acid,Then, 36.5 g of sodium bromide (0.354 moL) was added and then 30 g (99percent, 0.168 mol) of 4-trifluoromethoxyaniline was added.Adjust the temperature to above 30 ,Start dropping 35percent hydrogen peroxide 38g,When dropping temperature rise,When the temperature rose to 50 ,By controlling the cooling liquid dripping temperature control between 50 ~ 55 ,Keep the temperature drops off,Drip finished insulation 3 hours,Cooling to about 30 ,filter,Filter cake drying,White crystals of 2,6-dibromo-4-trifluoromethoxyaniline 55.8 g, purity99.6percent (HPLC), yield 99.2percent.
Reference: [1] Patent: CN106631839, 2017, A, . Location in patent: Paragraph 0022-0033
[2] Organic Letters, 2011, vol. 13, # 20, p. 5636 - 5639
  • 33
  • [ 1193-21-1 ]
  • [ 714962-04-6 ]
  • [ 461-82-5 ]
  • [ 778270-11-4 ]
Reference: [1] Patent: US2011/21524, 2011, A1,
  • 34
  • [ 461-82-5 ]
  • [ 778270-11-4 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 22, p. 9138 - 9141
  • 35
  • [ 870072-76-7 ]
  • [ 461-82-5 ]
  • [ 870544-59-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 4, p. 1704 - 1714
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 461-82-5 ]

Fluorinated Building Blocks

Chemical Structure| 1535-73-5

[ 1535-73-5 ]

3-Trifluoromethoxyaniline

Similarity: 0.98

Chemical Structure| 658-89-9

[ 658-89-9 ]

4-(Trifluoromethoxy)benzene-1,2-diamine

Similarity: 0.96

Chemical Structure| 22236-08-4

[ 22236-08-4 ]

3-(Difluoromethoxy)aniline

Similarity: 0.96

Chemical Structure| 22236-10-8

[ 22236-10-8 ]

4-(Difluoromethoxy)aniline

Similarity: 0.96

Chemical Structure| 1535-75-7

[ 1535-75-7 ]

2-(Trifluoromethoxy)aniline

Similarity: 0.92

Aryls

Chemical Structure| 1535-73-5

[ 1535-73-5 ]

3-Trifluoromethoxyaniline

Similarity: 0.98

Chemical Structure| 658-89-9

[ 658-89-9 ]

4-(Trifluoromethoxy)benzene-1,2-diamine

Similarity: 0.96

Chemical Structure| 22236-08-4

[ 22236-08-4 ]

3-(Difluoromethoxy)aniline

Similarity: 0.96

Chemical Structure| 22236-10-8

[ 22236-10-8 ]

4-(Difluoromethoxy)aniline

Similarity: 0.96

Chemical Structure| 1535-75-7

[ 1535-75-7 ]

2-(Trifluoromethoxy)aniline

Similarity: 0.92

Ethers

Chemical Structure| 1535-73-5

[ 1535-73-5 ]

3-Trifluoromethoxyaniline

Similarity: 0.98

Chemical Structure| 658-89-9

[ 658-89-9 ]

4-(Trifluoromethoxy)benzene-1,2-diamine

Similarity: 0.96

Chemical Structure| 22236-08-4

[ 22236-08-4 ]

3-(Difluoromethoxy)aniline

Similarity: 0.96

Chemical Structure| 22236-10-8

[ 22236-10-8 ]

4-(Difluoromethoxy)aniline

Similarity: 0.96

Chemical Structure| 1535-75-7

[ 1535-75-7 ]

2-(Trifluoromethoxy)aniline

Similarity: 0.92

Amines

Chemical Structure| 1535-73-5

[ 1535-73-5 ]

3-Trifluoromethoxyaniline

Similarity: 0.98

Chemical Structure| 658-89-9

[ 658-89-9 ]

4-(Trifluoromethoxy)benzene-1,2-diamine

Similarity: 0.96

Chemical Structure| 22236-08-4

[ 22236-08-4 ]

3-(Difluoromethoxy)aniline

Similarity: 0.96

Chemical Structure| 22236-10-8

[ 22236-10-8 ]

4-(Difluoromethoxy)aniline

Similarity: 0.96

Chemical Structure| 1535-75-7

[ 1535-75-7 ]

2-(Trifluoromethoxy)aniline

Similarity: 0.92

Trifluoromethyls

Chemical Structure| 1535-73-5

[ 1535-73-5 ]

3-Trifluoromethoxyaniline

Similarity: 0.98

Chemical Structure| 658-89-9

[ 658-89-9 ]

4-(Trifluoromethoxy)benzene-1,2-diamine

Similarity: 0.96

Chemical Structure| 1535-75-7

[ 1535-75-7 ]

2-(Trifluoromethoxy)aniline

Similarity: 0.92

Chemical Structure| 133115-72-7

[ 133115-72-7 ]

(4-(Trifluoromethoxy)phenyl)hydrazine hydrochloride

Similarity: 0.87

Chemical Structure| 933674-93-2

[ 933674-93-2 ]

2-Methyl-5-trifluoromethoxyaniline

Similarity: 0.85